M Ventures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 18

Professionals
  • Investments
  • 128

  • Portfolio
  • 58

  • Exits
  • 22

Exits

M Ventures General Information

Description

Founded in 2009, M Ventures is a corporate venture capital arm of Merck KGaA based in Amsterdam, Netherlands. The firm prefers to invest in seed-stage, early-stage, and later-stage companies. The firm seeks to invest in healthcare, information technology, materials, resources, life sciences, oncology, advanced manufacturing, internet of things, artificial intelligence, machine learning, and technology-based sectors.

Contact Information

Year Founded
2009
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Accelerator/Incubator
Primary Office
  • Gustav Mahlerplein 102
  • Toyo lto Building, 20th Floor
  • 1082 MA Amsterdam
  • Netherlands

M Ventures Investments (128)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Biolinq 27-May-2022 Later Stage VC 00000 Monitoring Equipment Product In Beta Test
0000000 30-Mar-2022 00000 00000 0000 Other Healthcare Technology Systems Generating Revenue 0000000 0000000000000 00.0
0000000 23-Feb-2022 00000 00000 00000 Drug Discovery Generating Revenue
000000 00000000000 22-Feb-2022 0000 00000 00.000 Drug Discovery Startup
000000000 00 04-Feb-2022 00000 00000 0000 Application Specific Semiconductors Stealth
000000 000000000 06-Jan-2022 00000 00000 00.000 Diagnostic Equipment Generating Revenue 0000000 0000000000000 00.0
00000000 000000000 29-Dec-2021 00000 00000 0000 Electronic Equipment and Instruments Generating Revenue
00000000000 01-Dec-2021 00000 00000 Other Healthcare Technology Systems Generating Revenue
DNA Script 26-Oct-2021 Later Stage VC 00000 Biotechnology Generating Revenue
iOmx Therapeutics 05-Oct-2021 Later Stage VC 000.00 Drug Discovery Pre-Clinical Trials
You’re viewing 10 of 128 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

M Ventures Exits (22)

Company Name Exit Date Exit Type Exit Size
Forendo Pharma 13-Dec-2021 Merger/Acquisition 00000
00000 000000000000 22-Oct-2021 000 00000
00000000 000000000 16-Sep-2021 000 00 00000000
0000000 000 0 10-Feb-2021 000 00 00000000
0-0000 00000000000 20-Nov-2020 0000000 000000
0000000 25-Oct-2019 000 00000
0000 0000 000 01-Sep-2019 000000000 00000000
000000000 01-Jan-2019 000 00 00000000
Neviah Genomics 01-Aug-2018 Out of Business
Translate Bio 28-Jun-2018 IPO 00000
You’re viewing 10 of 22 exits. Get the full list »

M Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

M Ventures Team (79)

Name Title Deals Funds Boards Office
Javier Rodriguez Chief Financial Officer Darmstadt, Germany
Hakan Goker Ph.D Managing Director Biotechnology 00 0 0 Amsterdam, Netherlands
Christian Patze Ph.D Investment Principal Technology 0 0 0 Cambridge, MA
Sarah Luppino Ph.D Investment Associate Technology Amsterdam, Netherlands
Therese Liechtenstein Ph.D Investment Principal Biotechnology 0 0 0 Amsterdam, Netherlands
You’re viewing 5 of 79 team members. Get the full list »

M Ventures Co-Investors (302)

Name With Exits Lead Partner Series Industry
Novartis Venture Fund 5 0 0 Series chart Industry bar
Alexandria Venture Investments 0 0 Series chart Industry bar
Pfizer Ventures 0 0 Series chart Industry bar
Applied Ventures 0 0 Series chart Industry bar
IP Group 0 0 Series chart Industry bar
You’re viewing 5 of 302 co-investors. Get the full list »